These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15743832)

  • 1. The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.
    Cardone M; Kandilci A; Carella C; Nilsson JA; Brennan JA; Sirma S; Ozbek U; Boyd K; Cleveland JL; Grosveld GC
    Mol Cell Biol; 2005 Mar; 25(6):2395-405. PubMed ID: 15743832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Id2 is dispensable for myc-induced lymphomagenesis.
    Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL
    Cancer Res; 2004 Oct; 64(20):7296-301. PubMed ID: 15492249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ETS factor TEL2 is a hematopoietic oncoprotein.
    Carella C; Potter M; Bonten J; Rehg JE; Neale G; Grosveld GC
    Blood; 2006 Feb; 107(3):1124-32. PubMed ID: 16234363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myc suppression of Nfkb2 accelerates lymphomagenesis.
    Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
    BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
    Hemann MT; Bric A; Teruya-Feldstein J; Herbst A; Nilsson JA; Cordon-Cardo C; Cleveland JL; Tansey WP; Lowe SW
    Nature; 2005 Aug; 436(7052):807-11. PubMed ID: 16094360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6.
    Potter MD; Buijs A; Kreider B; van Rompaey L; Grosveld GC
    Blood; 2000 Jun; 95(11):3341-8. PubMed ID: 10828014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
    Kawagoe H; Potter M; Ellis J; Grosveld GC
    Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIF loss impairs Myc-induced lymphomagenesis.
    Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
    Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.
    Mathas S; Rickers A; Bommert K; Dörken B; Mapara MY
    Cancer Res; 2000 Dec; 60(24):7170-6. PubMed ID: 11156427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
    Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M
    Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-hypermutated isoforms of MYC protein: Tumour-suppressor P-53 protective-initiation of apoptosis that normally prevents Burkitt's lymphoma tumorigenesis can be enhanced.
    Wiseman A
    Med Hypotheses; 2006; 66(5):1046-7. PubMed ID: 16413684
    [No Abstract]   [Full Text] [Related]  

  • 12. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis.
    Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I
    Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nfkb 1 is dispensable for Myc-induced lymphomagenesis.
    Keller U; Nilsson JA; Maclean KH; Old JB; Cleveland JL
    Oncogene; 2005 Sep; 24(41):6231-40. PubMed ID: 15940251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma.
    Scheller H; Tobollik S; Kutzera A; Eder M; Unterlehberg J; Pfeil I; Jungnickel B
    Oncogene; 2010 Feb; 29(6):888-97. PubMed ID: 19881537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
    Ben-Yosef T; Yanuka O; Benvenisty N
    Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures.
    Johnston HE; Carter MJ; Cox KL; Dunscombe M; Manousopoulou A; Townsend PA; Garbis SD; Cragg MS
    Mol Cell Proteomics; 2017 Mar; 16(3):386-406. PubMed ID: 28062796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bim is a suppressor of Myc-induced mouse B cell leukemia.
    Egle A; Harris AW; Bouillet P; Cory S
    Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6164-9. PubMed ID: 15079075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant mice lacking alternatively spliced p53 isoforms unveil
    Fajac A; Simeonova I; Leemput J; Gabriel M; Morin A; Lejour V; Hamon A; Rakotopare J; Vaysse-Zinkhöfer W; Eldawra E; Pinskaya M; Morillon A; Bourdon JC; Bardot B; Toledo F
    Elife; 2024 Sep; 13():. PubMed ID: 39298333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis.
    Garrison SP; Jeffers JR; Yang C; Nilsson JA; Hall MA; Rehg JE; Yue W; Yu J; Zhang L; Onciu M; Sample JT; Cleveland JL; Zambetti GP
    Mol Cell Biol; 2008 Sep; 28(17):5391-402. PubMed ID: 18573879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.